Request for Nominations to the SAMHSA National Advisory Council, 44862 [E9-20884]
Download as PDF
<![CDATA[
44862
Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices
license or passport. All visitors should
be prepared to have their personal
belongings inspected and to go through
metal detection inspection.
When driving to NIH, plan some extra
time to get through the security
checkpoints at the visitor entrances to
campus. Be aware that visitor parking
lots on the NIH campus can fill up
quickly. The NIH campus is also
accessible via the metro Red Line,
Medical Center Station. The Natcher
Conference Center is a 5-minute walk
from the Medical Center Metro Station.
Additional NIH campus visitor
information is available at: https://
www.nih.gov/about/visitor/index.htm.
Information about the IACC and a
registration link for this meeting are
available on the Web site: https://
www.iacc.hhs.gov.
Dated: August 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20872 Filed 8–28–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
cprice-sewell on DSK2BSOYB1PROD with NOTICES
Request for Nominations to the
SAMHSA National Advisory Council
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is accepting nominations
through October 7, 2009, to fill
vacancies for its five advisory
committees (the SAMHSA National
Advisory Council, the Center for
Substance abuse Prevention, Center for
Substance Abuse Treatment and Center
for Mental Health Services National
Advisory Councils and the Advisory
Committee for Women’s Services).
Under section 502 of the Public Health
Service Act, the National Advisory
Councils (NAC) provide advice to the
Secretary of the U.S. Department of
Health and Human Services (HHS),
SAMHSA Administrator, and/or Center
Directors on a broad range of polices
and services related to substance use
and mental health.
Legislation requires that each NAC be
composed of 12 members: nine
members must be leading
representatives of the health disciplines
(including public health, behavioral
health, and social sciences) relevant to
the mission of SAMHSA and its Centers
and three members must be from the
general public and include leaders in
the fields of public policy, public
VerDate Nov<24>2008
14:57 Aug 28, 2009
Jkt 217001
relations, law, health policy, economics,
or management.
Under section 501 of the Public
Health Service Act, the Advisory
Committee for Women’s Services
(ACWS) is statutorily mandated to
advise the SAMHSA Administrator and
the Associate Administrator for
Women’s Services on appropriate
activities to be undertaken by SAMHSA
and its Centers with respect to women’s
substance abuse and mental health
services. The SAMHSA Administrator
will appoint the 10 members of this
Committee. The members must be from
among physicians, practitioners,
treatment providers, and other health
professionals, whose clinical practice,
specialization, or professional expertise
includes a significant focus on women’s
substance abuse and mental health
conditions.
The current lists of members for the
advisory committees are available on
the SAMHSA Web site at https://
nac.samhsa.gov/index.aspx.
Members are appointed for a term of
up to four years. Individuals are
nominated, selected, and appointed to a
NAC or the ACWS to contribute to the
advisory committee’s objectives based
on their qualifications. The Federal
Advisory Committee Act (FACA) and
HHS policy require that committee
membership be fairly balanced in terms
of points of view represented and the
committee’s functions to be performed.
Consideration is given to a broad
representation of geographic areas,
gender, race/ethnicity, and disability.
The advisory committees will meet not
less than two times per year and on an
as needed basis.
Any interested person or organization
may nominate qualified individuals for
membership. Self-nominations are also
welcome. Nominations must include a
resume and short biography describing
the educational and professional
qualifications of the nominee and the
nominee’s current occupation, position,
address and daytime telephone number.
Individuals may be recommended for
membership on more than one advisory
committee, but will be appointed to
only one advisory body. Nominations
can be sent by U.S. Mail or
electronically to Ms. Toian Vaughn,
Designated Federal Official, at the
address below.
Contact: Toian Vaughn, M.S.W.,
Designated Federal Official, SAMHSA
National Advisory Council and
SAMHSA Committee Management
Officer, 1 Choke Cherry Road, Room 8–
1089, Rockville, Maryland 20857.
Telephone: (240) 276–2307; Fax: (240)
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
276–2220 and E-mail:
toian.vaughn@samhsa.hhs.gov.
Toian Vaughn,
Committee Management Officer, Substance
Abuse and Mental Health Services
Administration.
[FR Doc. E9–20884 Filed 8–28–09; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Development of AntiAngiogenesis Cancer Therapeutics
Targeting Adrenomedullin or
Proadrenomedullin N-Terminal 20
Peptide (PAMP)
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health (NIH), Department
of Health and Human Services, is
contemplating the grant of an exclusive
patent license to practice the inventions
embodied in U.S. Patent Application
No. 60/002,514, filed on August 18,
1995, entitled ‘‘Functional Role of
Adrenomedullin (AM) and the GeneRelated Product (PAMP) in Human
Pathology and Physiology’’ (HHS
Reference No. E–206–1995/0–US–01);
U.S. Patent Application No. 60/002,936,
filed on August 30, 1995, entitled
‘‘Functional Role of Adrenomedullin
(AM) and the Gene-Related Product
(PAMP) in Human Pathology and
Physiology’’ (HHS Reference No. E–
206–1995/1–US–01); U.S. Patent
Application No. 60/013,172, filed on
March 12, 1996, entitled ‘‘Functional
Role of Adrenomedullin (AM) and the
Gene-Related Product (PAMP) in
Human Pathology and Physiology’’
(HHS Reference No. E–206–1995/2–US–
01); PCT Application No. PCT/US96/
13286, filed on August 16, 1996,
entitled ‘‘Functional Role of
Adrenomedullin (AM) and the GeneRelated Product (PAMP) in Human
Pathology and Physiology’’ (HHS
Reference No. E–206–1995/3–PCT–01);
Australian Patent No. 710662, issued on
October 5, 2000, entitled ‘‘Functional
Role of Adrenomedullin (AM) and the
Gene-Related Product (PAMP) in
Human Pathology and Physiology’’
(HHS Reference No. E–206–1995/3–AU–
02); Canadian Patent Application No.
2229741, filed on August 16, 1996,
entitled ‘‘Functional Role of
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 74, Number 167 (Monday, August 31, 2009)]
[Notices]
[Page 44862]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20884]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Request for Nominations to the SAMHSA National Advisory Council
The Substance Abuse and Mental Health Services Administration
(SAMHSA) is accepting nominations through October 7, 2009, to fill
vacancies for its five advisory committees (the SAMHSA National
Advisory Council, the Center for Substance abuse Prevention, Center for
Substance Abuse Treatment and Center for Mental Health Services
National Advisory Councils and the Advisory Committee for Women's
Services). Under section 502 of the Public Health Service Act, the
National Advisory Councils (NAC) provide advice to the Secretary of the
U.S. Department of Health and Human Services (HHS), SAMHSA
Administrator, and/or Center Directors on a broad range of polices and
services related to substance use and mental health.
Legislation requires that each NAC be composed of 12 members: nine
members must be leading representatives of the health disciplines
(including public health, behavioral health, and social sciences)
relevant to the mission of SAMHSA and its Centers and three members
must be from the general public and include leaders in the fields of
public policy, public relations, law, health policy, economics, or
management.
Under section 501 of the Public Health Service Act, the Advisory
Committee for Women's Services (ACWS) is statutorily mandated to advise
the SAMHSA Administrator and the Associate Administrator for Women's
Services on appropriate activities to be undertaken by SAMHSA and its
Centers with respect to women's substance abuse and mental health
services. The SAMHSA Administrator will appoint the 10 members of this
Committee. The members must be from among physicians, practitioners,
treatment providers, and other health professionals, whose clinical
practice, specialization, or professional expertise includes a
significant focus on women's substance abuse and mental health
conditions.
The current lists of members for the advisory committees are
available on the SAMHSA Web site at https://nac.samhsa.gov/index.aspx.
Members are appointed for a term of up to four years. Individuals
are nominated, selected, and appointed to a NAC or the ACWS to
contribute to the advisory committee's objectives based on their
qualifications. The Federal Advisory Committee Act (FACA) and HHS
policy require that committee membership be fairly balanced in terms of
points of view represented and the committee's functions to be
performed. Consideration is given to a broad representation of
geographic areas, gender, race/ethnicity, and disability. The advisory
committees will meet not less than two times per year and on an as
needed basis.
Any interested person or organization may nominate qualified
individuals for membership. Self-nominations are also welcome.
Nominations must include a resume and short biography describing the
educational and professional qualifications of the nominee and the
nominee's current occupation, position, address and daytime telephone
number. Individuals may be recommended for membership on more than one
advisory committee, but will be appointed to only one advisory body.
Nominations can be sent by U.S. Mail or electronically to Ms. Toian
Vaughn, Designated Federal Official, at the address below.
Contact: Toian Vaughn, M.S.W., Designated Federal Official, SAMHSA
National Advisory Council and SAMHSA Committee Management Officer, 1
Choke Cherry Road, Room 8-1089, Rockville, Maryland 20857. Telephone:
(240) 276-2307; Fax: (240) 276-2220 and E-mail:
toian.vaughn@samhsa.hhs.gov.
Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health
Services Administration.
[FR Doc. E9-20884 Filed 8-28-09; 8:45 am]
BILLING CODE 4162-20-P
